ARTICLE
Journal of Stem Cells and Regenerative Medicine has published a research article submitted by NJ Sharing Network’s Prakash Rao, Dayanand Deo, and Misty Marchioni. The article, entitled “Differentiation of Human Deceased Donor, Adipose-Derived, Mesenchymal Stem Cells into Functional Beta Cells,” details a promising therapeutic approach for cell replacement therapy to potentially offer a new treatment approach for patients with Type 1 Diabetes. The research was carried out at the Personalized Transplant Medicine Institute (PTMI) of the NJ Sharing Network. The Journal of Stem Cells and Regenerative Medicine, an official journal of the German Society for Stem Cell Research (GSZ), reaches millions of researchers, clinicians and students all over the world. The journal covers areas of basic research, translational work and clinical studies in the specialty of Stem Cells and Regenerative Medicine. “We are honored that our Transplant Laboratory’s latest world-class research and findings have been published in the Journal of Stem Cells and Regenerative Medicine,” said Joe Roth, president and CEO of NJ Sharing Network. “It is another distinguished recognition of how our Transplant Laboratory professionals are committed to transforming ‘transplantology’ by focusing on solutions that enable more people to receive life-saving transplants faster, increase the quality of life for transplant recipients, and maximize the use of donated organs.” NJ Sharing Network’s state-of-the-art Transplant Laboratory performs histocompatibility testing for deceased and living organ donors and recipients. The Transplant Laboratory also plays a critical role in the pre and post-transplant evaluation, and successful transplantation of highly sensitized individuals who would be difficult to treat under general conditions.